Abstract:Small molecule drugs play a pivotal role in the arsenal of anticancer pharmacological agents. Nonetheless, their small size poses a challenge when directly visualizing their localization, distribution, mechanism of action (MOA), and target engagement at the subcellular level in real time. We propose a strategy for developing triple-functioning drug beacons that seamlessly integrate therapeutically relevant bioactivity, precise subcellular localization, and direct visualization capabilities within a single molecular entity. As a proof of concept, we have meticulously designed and constructed a boronic acid fluorescence drug beacon using coumarin–hemicyanine (CHB). Our CHB design includes three pivotal features: a boronic acid moiety that binds both adenosine triphosphate (ATP) and adenosine diphosphate (ADP), thus depleting their levels and disrupting the energy supply within mitochondria; a positively charged component that targets the drug beacon to mitochondria; and a sizeable conjugated luminophore that emits fluorescence, facilitating the application of structured illumination microscopy (SIM). Our study indicates the exceptional responsiveness of our proof-of-concept drug beacon to ADP and ATP, its efficacy in inhibiting tumor growth, and its ability to facilitate the tracking of ADP and ATP distribution around the mitochondrial cristae. Furthermore, our investigation reveals that the micro-dynamics of CHB induce mitochondrial dysfunction by causing damage to the mitochondrial cristae and mitochondrial DNA. Altogether, our findings highlight the potential of SIM in conjunction with visual drug design as a potent tool for monitoring the in situ MOA of small molecule anticancer compounds. This approach represents a crucial advancement in addressing a current challenge within the field of small molecule drug discovery and validation.

Dual-Signal Chemical Exchange Saturation Transfer (Dusi-CEST): An Efficient Strategy for Visualizing Drug Delivery Monitoring in Living Cells

Binding affinity-based intracellular drug detection enabled by a unimolecular cucurbit[7]uril-dye conjugate

Ultraefficient Cap-Exchange Protocol To Compact Biofunctional Quantum Dots for Sensitive Ratiometric Biosensing and Cell Imaging.

A Coumarin-Based Reversible Fluorescent Probe For Cu2+ And S2- And Its Applicability In Vivo And For Organism Imaging

In vivo detection of cucurbit[6]uril, a hyperpolarized xenon contrast agent for a xenon magnetic resonance imaging biosensor

A Novel Peptide-Based Fluorescent Probe with a Large Stokes Shift for Rapid and Sequential Detection of Cu2+ and CN- in Aqueous Systems and Live Cells

A Bioorthogonal Dual Fluorogenic Probe for the Live‐Cell Monitoring of Nutrient Uptake by Mammalian Cells

Non-invasive, Real-Time Reporting Drug Release in Vitro and in Vivo.

Imaging two targets in live cells based on rational design of lanthanide organic structure appended carbon dots

Dual-Site Fluorescent Probe For Visualizing The Metabolism Of Cys In Living Cells

CEST MRI trackable nanoparticle drug delivery systems

Directly Functionalized Cucurbit[7]uril As a Biosensor for the Selective Detection of Protein Interactions by 129 Xe Hypercest NMR.

Carbon-Dot and Quantum-Dot-Coated Dual-Emission Core–Satellite Silica Nanoparticles for Ratiometric Intracellular Cu2+ Imaging

Super-resolution imaging for in situ monitoring sub-cellular micro-dynamics of small molecule drug

A resumable two-photon fluorescent probe for Cu2+ and S2- based on magnetic silica core-shell Fe3O4@SiO2 nanoparticles and its application in bioimaging.

Dynamic Interconversions of Single Molecules Probed by Recognition Tunneling at Cucurbit[7]uril‐Functionalized Supramolecular Junctions

A Novel Fluorescent Probe with Dual-Sites for Simultaneously Monitoring Metabolisms of Cysteine in Living Cells and Zebrafishes

A New Intramolecular Proton Transfer (esipt)‐based Fluorescent Probe for Selective Visualization of Cyanide Ion

A Turn-On Fluorescent Probe for Sensitive Detection of Cysteine in a Fully Aqueous Environment and in Living Cells

Intracellular Targeted Delivery of Quantum Dots with Extraordinary Performance Enabled by a Novel Nanomaterial Design.

A Cis-Diol/ph Dual-Responsive Upconversion Nanoplatform: Synthesis, Characterization, and in Vitro Demonstration.